Mylan Speaks To Zagam.Business Editors PITTSBURGH--(BUSINESS WIRE)--Feb. 16, 2001 Mylan Laboratories Inc. (NYSE NYSE See: New York Stock Exchange :MYL MYL Mind Your Language MYL Made You Laugh MYL Miss You Lots MYL Meet You Later MYL Miss You Loads ) has indicated that they are presently marketing the antibiotic antibiotic, any of a variety of substances, usually obtained from microorganisms, that inhibit the growth of or destroy certain other microorganisms. Types of Antibiotics , Zagam(R), and it remains a part of their Bertek branded product line. Mylan wrote down $3.6 million of the Zagam(R) product license asset in their third quarter, which was reported on January 30, 2001, because of supply issues. Mylan continues to work to try and resolve the issues surrounding Zagam(R). Mylan Laboratories Inc., is one of the largest manufacturers and marketers of prescription generic pharmaceuticals in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Mylan also develops and markets branded pharmaceutical products through its Bertek Pharmaceuticals Inc. subsidiary. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion